The Neuroprotective and Anti-inflammatory Effects of Diltiazem in Spinal Cord Ischaemia-Reperfusion Injury

被引:22
作者
Fansa, I. [1 ]
Altug, M. E. [6 ]
Melek, I. [2 ]
Ucar, E. [3 ]
Kontas, T. [7 ]
Akcora, B. [4 ]
Atik, E. [5 ]
Duman, T. [2 ]
机构
[1] Mustafa Kemal Univ, Dept Cardiovasc Surg, Fac Med, Antakya, Turkey
[2] Mustafa Kemal Univ, Dept Neurol, Fac Med, Antakya, Turkey
[3] Mustafa Kemal Univ, Dept Internal Med, Fac Med, Antakya, Turkey
[4] Mustafa Kemal Univ, Dept Paediat Surg, Fac Med, Antakya, Turkey
[5] Mustafa Kemal Univ, Dept Pathol, Fac Med, Antakya, Turkey
[6] Mustafa Kemal Univ, Dept Surg, Fac Vet Med, Antakya, Turkey
[7] Mustafa Kemal Univ, Dept Biochem, Fac Vet Med, Antakya, Turkey
关键词
DILTIAZEM; SPINAL CORD ISCHAEMIA; ANIMAL MODEL; INFLAMMATORY CYTOKINES; FREE RADICALS; CONGESTIVE-HEART-FAILURE; BLOOD-FLOW; CHANNEL BLOCKER; THORACOABDOMINAL AORTA; NEUROLOGIC INJURY; WHITE-MATTER; RABBIT MODEL; CELL-DEATH; PROTECTION; RAT;
D O I
10.1177/147323000903700228
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
100103 [病原生物学]; 100218 [急诊医学];
摘要
The protective effects of diltiazem were examined in a rabbit model of spinal cord ischaemia-reperfusion induced by infrarenal aortic occlusion for 30 min. In the diltiazem group (n = 6), an intravenous infusion (2 mu g/kg per min) was started 10 min before ischaemia induction; normal saline solution was infused in the control group (n = 6). Neurological function was assessed using modified Tarlov criteria 24 h after surgery. Plasma samples were analysed for interleukin (IL)-6 and IL-10. Spinal tissue was analysed for malondialdehyde, nitric oxide and reduced glutathione activities. Tarlov scores of the diltiazem-treated rabbits indicated significantly improved hind-limb motor function compared with the control group. The diltiazem group also had better quantitative and qualitative histopathological findings. Diltiazem infusion significantly reduced IL-6 levels 3 and 24 h after reperfusion compared with the control group. The mean IL-10 level in the diltiazem group was significantly higher than in the control group 24 h after reperfusion. It is concluded that diltiazem has cytoprotective and anti-inflammatory properties, leading to reduced spinal cord injury.
引用
收藏
页码:520 / 533
页数:14
相关论文
共 55 条
[1]
BLAY JY, 1993, BLOOD, V82, P2169
[2]
Endothelial cell injury in cardiovascular surgery: Ischemia-reperfusion [J].
Boyle, EM ;
Pohlman, TH ;
Cornejo, CJ ;
Verrier, ED .
ANNALS OF THORACIC SURGERY, 1996, 62 (06) :1868-1875
[3]
The neuroprotective effects of intrathecal administration of the selective N-type calcium channel blocker ziconotide in a rat model of spinal ischemia [J].
Burns, LH ;
Jin, Z ;
Bowersox, SS .
JOURNAL OF VASCULAR SURGERY, 1999, 30 (02) :334-343
[4]
Pharmacological preconditioning ameliorates neurological injury in a model of spinal cord ischemia [J].
Caparrelli, DJ ;
Cattaneo, SM ;
Bethea, BT ;
Shake, JG ;
Eberhart, C ;
Blue, ME ;
Marbán, E ;
Johnston, MV ;
Baumgartner, WA ;
Gott, VL .
ANNALS OF THORACIC SURGERY, 2002, 74 (03) :838-844
[5]
Systemic adenosine A2A agonist ameliorates ischemic reperfusion injury in the rabbit spinal cord [J].
Cassada, DC ;
Gangemi, JJ ;
Rieger, JM ;
Linden, J ;
Kaza, AK ;
Long, SM ;
Kron, IL ;
Tribble, CG ;
Kern, JA .
ANNALS OF THORACIC SURGERY, 2001, 72 (04) :1245-1250
[6]
Adenosine A2A agonist reduces paralysis after spinal cord ischemia:: Correlation with A2A receptor expression on motor neurons [J].
Cassada, DC ;
Tribble, CG ;
Long, SM ;
Kaza, AK ;
Linden, J ;
Rieger, JM ;
Rosin, D ;
Kron, IL ;
Kern, JA .
ANNALS OF THORACIC SURGERY, 2002, 74 (03) :846-849
[7]
BLOOD-FLOW AND ELECTROLYTES IN SPINAL-CORD ISCHEMIA [J].
CHAVKO, M ;
KALINCAKOVA, K ;
KLUCHOVA, D ;
NEMOTO, E .
EXPERIMENTAL NEUROLOGY, 1991, 112 (03) :299-303
[8]
Protective effect of diltiazem on hepatic ischemia-reperfusion injury in rats by improving liver tissue blood flow [J].
Chin, S ;
Ikeda, M ;
Ozaki, M ;
Kameoka, S .
TRANSPLANTATION PROCEEDINGS, 2005, 37 (10) :4556-4559
[9]
Coselli JS, 1997, J VASC SURG, V25, P241
[10]
Diltiazem reduces apoptosis in rat hepatocytes subjected to warm hypoxia-reoxygenation [J].
Crenesse, D ;
Tornieri, K ;
Laurens, M ;
Heurteaux, C ;
Cursio, R ;
Gugenheim, J ;
Schmid-Alliana, A .
PHARMACOLOGY, 2002, 65 (02) :87-95